For The Better

The good news out of OPEC wasn’t necessarily that good for energy companies.

COVID-19 concerns are back again.

The red-hot cloud communications sector is cooling down thanks to widespread vaccination against COVID-19.

Hecla Mining had a lot going for it, and it wasn’t just silver prices.

The Dow was down more than 750 points Monday morning.

The company’s AR technology is finally starting to reveal its value.

The July mARKet update webinar. This month’s spotlight: ARK’s latest research on the biopharmaceutical pipeline, the online sports betting…

Investors weren’t happy with the company’s mounting losses.

The company appears to be declining along with the broader market amid macroeconomic and pandemic-induced concerns.

Investors are concerned about Square’s growing dependency on cryptocurrency revenue.

Earnings season is upon us — here’s your playbook.

Sentiment around the company’s key end market is negative today.

Investors are afraid of the effects of the delta variant.

Remember COVID-19? Guess what?

The company reported promising data for its experimental COVID-19 drug Zyesami.

The company’s new heart drug candidate produced encouraging clinical trial results.

Disappointing quarterly results and management issues plagued the company earlier this year.

Investors are betting on stronger uranium markets.